Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, November 2014

Sort by: Newest first Oldest first A-Z Z-A

  • Antibiotic resistance a 'threat to public safety' in Europe Subscription

    18 NOV 2014 15:45

    Increasing bacterial resistance across Europe, particularly to carbapenems and polymixin antibiotics, is a “threat to public safety”.

  • App for reducing risk of non-communicable diseases Subscription

    7 NOV 2014 9:49

    The World Health Professions Alliance, supported by the International Federation of Pharmaceutical Manufacturers and Associations, have launched an app to help individuals and their health professionals reduce the risk of non-communicable diseases. The app, called HealthyScore, helps individuals rate their habits with a traffic light system. Four biometric indicators and four behaviour indicators provide ...

  • Aureocort, demeclocycline, diloxanide and Hydrocortistab out of stock Subscription

    21 NOV 2014 10:16

    The following products are out of stock from Amdipharm Mercury: Aureocort (chlortetracycline hydrochloride/triamcinolone acetonide) ointment 3.09%/1%w/w, 15g; Co-phenotrope (diphenoxylate hydrochloride/atropine sulphate) tablets 2.5/0.25mg x 100; demeclocycline hydrochloride capsules 150mg x 28; diloxanide tablets 500mg x 30; Hydrocortistab (hydrocortisone acetate) injection ampoules 25mg/ml x 10. Supply is expected to resume by June 2015.

  • hypertension-blood-pressure-monitor

    Blood pressure devices giving inaccurate readings, study finds Subscription

    31 OCT 2014 14:00 By Coeli Carr
    Comments (3)

    Blood pressure devices designed for use at home can give inaccurate readings for as many as 15% of users.

  • Breastfeeding mothers may lose out if recent domperidone warnings are heeded Subscription

    19 NOV 2014 14:45

    The benefits of using domperidone to increase milk supply in breastfeeding mothers outweigh its risks, argues a researcher at the University of Adelaide, South Australia.

  • Bupivicaine, digoxin, Deltastab and Hytrin out of stock Subscription

    21 NOV 2014 10:11

    The following products are out of stock from Amdipharm Mercury: bupivacaine hydrochloride solution for infusion 0.1%w/v and 0.125%w/v, both 250ml x 20; digoxin solution for injection 250µg/ml, 2ml x 10; Deltastab (prednisolone acetate) injection ampoules 25mg/ml x 10; Hytrin (terazosin) tablets 10mg. Supply is expected to resume in February 2015.

  • Pharmacists and GPs in Wales call to raise awareness of risks of buying antibiotics from unlicensed websites

    Call to raise awareness of the risks of buying antibiotics from unlicensed websites Subscription

    18 NOV 2014 10:01 By Stephen Robinson

    Pharmacists and GPs in Wales call for steps to underline the risks of buying antibiotics online without a prescription.

  • Case of bird flu confirmed in UK Subscription

    17 NOV 2014 16:31

    A case of avian influenza has been confirmed in the UK by the Department for Environment, Food and Rural Affairs.

  • Chlamydia screening services Subscription

    17 NOV 2014 9:54

    Public Health England (PHE) has published guidance to support commissioning of high quality chlamydia screeening services in general practice and community pharmacies. The guidance is available from PHE’s website.

  • Class 2 medicines recall for mitoxantrone Subscription

    26 NOV 2014 16:40

    The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall (action within 48 hours) for mitoxantrone 2mg/ml concentrate for solution for infusion, manufactured by Hospira UK Limited. This is because of a number of confirmed out of specification test results obtained during stability studies. Pharmacists should quarantine any remaining stock and Hospira will contact customers who may have received the impacted batches to arrange collection via ...

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.